Here’s what you should know:
1. Researchers are launching a randomized, double-blind, placebo-controlled clinical trial to test the effectiveness of Biomerica’s IBS therapy.
2. The InFoods IBS product allows physicians to identify specific foods that impact a patient’s IBD. If approved, physicians will be able to take a finger stick blood sample to find foods that impact IBS.
3. The study is being conducted at Boston-based Beth Israel Deaconess Medical Center and Ann Arbor-based University of Michigan.
4. The trial will include 180 patients and last up to 14 months.
5. The study results will be used in a FDA 510(k) application seeking FDA approval for the therapy.
More articles on gastroenterology:
TVA Medical to introduce FDA-approved endovascular fistula creation method at surgery centers — 5 insights
Implementing a total joint replacement program in your ASC: 4 lessons from OrthoIllinois Surgery Center
30k joint replacements for SurgCenter Development & more — 8 ASC company key notes
